| Clinical Trial on Pharmacokinetics and Tolerability of AP707 (NCT05267769) | CannaXan GmbH | 2022-03-02 |
| Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors (NCT05142592) | Nanjing Immunophage Biotech Co., Ltd | 2021-11-15 |
| Study Evaluating the Safety and Tolerability of a Probioitc (NCT05044949) | BioGaia AB | 2021-11-01 |
| Safety, Tolerability and Pharmacokinetics of AM1476 in Healthy Subjects (NCT04691115) | AnaMar AB | 2020-12-16 |
| Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+ (NCT04693429) | Laboratorios Sophia S.A de C.V. | 2020-09-24 |
| Clinical Trial on Pharmacokinetic and Tolerability of AP701 (NCT04708795) | CannaXan GmbH | 2020-01-11 |
| Feasibility, Tolerability and Efficacy of the Ketogenic Diet in Children With Drug-resistant Epilepsy in South Vietnam (NCT05697887) | Number 2 Children's Hospital, Ho Chi Minh City | 2019-06-01 |
| Safety, Tolerability and Immune Effects of the Nasal Foralumab in Healthy Human Volunteers (NCT06879067) | Tiziana Life Sciences LTD | 2018-11-12 |
| TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms (NCT03503968) | Medigene AG | 2018-03-27 |
| A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567. (NCT02512575) | AstraZeneca | 2015-11-18 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy Males (NCT02484729) | AstraZeneca | 2015-07-01 |
| Assessment of Novel Respiratory Protective Devices in Healthcare (NCT02082158) | National Center for Occupational Health and Infection Control | 2014-07-01 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants (NCT02209506) | Takeda | 2014-07-01 |
| Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants. (NCT02107885) | Daiichi Sankyo | 2014-03-01 |
| Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects (NCT02054754) | e-Therapeutics PLC | 2014-01-01 |
| To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects (NCT01818869) | AstraZeneca | 2014-01-01 |
| A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans (NCT01981928) | Astellas Pharma Europe B.V. | 2013-11-01 |
| A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal (NCT01959685) | Repros Therapeutics Inc. | 2013-10-01 |
| Evaluation of Experimental Heat Patch (NCT01841788) | Chattem, Inc. | 2012-10-01 |
| Evaluation of Experimental and Commercial Air-Activated, Adhesive Backed Heat Patches (NCT01841801) | Chattem, Inc. | 2012-10-01 |
| Music During Diagnostic Hysteroscopy (NCT01703871) | Campus Bio-Medico University | 2012-09-01 |
| Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects (NCT02206204) | Actelion | 2012-06-01 |
| Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206 (NCT01954589) | Idorsia Pharmaceuticals Ltd. | 2011-11-01 |
| Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study (NCT01158755) | Universitas Padjadjaran | 2010-10-01 |
| Single Centre, Double-blind, Single and Multiple Ascending Inhaled Doses of AZD9819 in Healthy Subjects (NCT01166698) | AstraZeneca | 2010-08-01 |
| Assessing the Safety and Tolerability of a Single IV Dose of AZD9742 in Healthy Elderly Male and Female Subjects (NCT01154621) | AstraZeneca | 2010-06-01 |
| Study to Investigate Single Ascending Oral Doses of AZD5213 in Healthy Male and Non Fertile Female Subjects (NCT01121302) | AstraZeneca | 2010-05-01 |
| Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043 (NCT01086813) | AstraZeneca | 2010-03-01 |
| Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis. (NCT00967317) | Laboratorios Osorio de Moraes Ltda. | 2009-12-01 |
| Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients (NCT01023282) | NeuroSearch A/S | 2009-11-01 |
| Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety (NCT00944268) | Ativus Farmaceutica Ltda | 2009-09-01 |
| Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid Tumor (NCT01260025) | Sun Yat-sen University | 2009-09-01 |